Live website intelligence
Official Home Page of the Apellis Pharmaceuticals Corporate Site | Apellis Pharmaceuticals
Apellis is a global biopharmaceutical company that develops life-changing therapies. By pioneering targeted C3 therapies, we aim to treat diseases that are driven by excessive activation of the complement cascade, including those within hematology, ophthalmology, and nephrology.
Last refresh
Updated 15d ago
Analyst read
Professional
Detected stack
Quick read
How to read apellis.com quickly
apellis.com looks like health & wellness. Traffic signals point to roughly 29.8K monthly visits. Current AI trust scoring is 5/100.
What to do next
- The stack appears to include WordPress.
- Open the Traffic tab if you need audience scale and geography before outreach.
- Open the Business tab if trust, monetization, or positioning is your first decision filter.
Provider Completeness
51/56 fields populated (91%)
Providers with missing fields
View field-level status
visual: 4/4
All expected fields present
meta: 3/3
All expected fields present
seo: 5/5
All expected fields present
dns: 4/4
All expected fields present
ads: 5/5
All expected fields present
publisher: 3/5
Missing: directCount, resellerCount
files: 2/3
Missing: robotsSitemapUrls
traffic: 10/10
All expected fields present
whois: 6/6
All expected fields present
radar: 2/4
Missing: categories, sourceTimestamp
ai: 7/7
All expected fields present
Why this module matters
Business signals help answer “is this a real opportunity?”
Use the business tab to understand trust, monetization, audience fit, and brand posture before you spend time on outreach, partnerships, or competitive teardown work.
- Trust score and sentiment are your first risk screen.
- Business summary and audience notes speed up qualification.
- Ads and monetization patterns reveal how the site captures value.
Business Intelligence
Business Profile
Apellis Pharmaceuticals is a global biopharmaceutical company developing targeted C3 therapies to treat diseases driven by excessive complement cascade activation, with focus areas in hematology, ophthalmology, and nephrology.
Classification
Trust & Risk
Trust Assessment
Google Ads Transparency
Publisher Monetization
Monetization Signals
AI Visual Analysis
IAB Taxonomy
Business Insights
Business Model
B2B2C (Biopharma R&D with patient-focused outcomes) model detected
Trust Level
Low trust with 5/100 score
Audience
Healthcare providers, patients with complement-mediated diseases, investors, and medical researchers
Keep exploring
Keep exploring from this report
Good pSEO pages should not strand the visitor. These links keep the journey moving through adjacent directories and comparable live reports.